未登录

N

Nesrina Imami

imperial college london

H指数:33

被引数:3,463

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Use of laboratory-developed assays in global HIV-1 treatment-monitoring and research

SCIENTIFIC REPORTS

IF3.9

2023-03-204

OAAI

Development of a sensitive, quantitative assay with broad subtype specificity for detection of total HIV-1 nucleic acids in plasma and PBMC (vol 12, 1550, 2022)

SCIENTIFIC REPORTS

IF3.9

2022-07-111

OAAI

Development of a sensitive, quantitative assay with broad subtype specificity for detection of total HIV-1 nucleic acids in plasma and PBMC (vol 12, 1550, 2022)

SCIENTIFIC REPORTS

IF3.9

2022-02-011

OAAI

Development of a sensitive, quantitative assay with broad subtype specificity for detection of total HIV-1 nucleic acids in plasma and PBMC

SCIENTIFIC REPORTS

IF3.9

2022-01-2811

OAAI

Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+T cell decline and increased immune activation during acute infection

IF4.9

2020-09-0412

OAAI

Pregnancy Gestation Impacts on HIV-1-Specific Granzyme B Response and Central Memory CD4 T Cells

FRONTIERS IN IMMUNOLOGY

IF5.9

2020-02-111

OAAI

Human labour is associated with altered regulatory T cell function and maternal immune activation

CLINICAL AND EXPERIMENTAL IMMUNOLOGY

IF3.8

2019-11-0313

OAAI

Progesterone-Related Immune Modulation of Pregnancy and Labor

孕激素相关的妊娠和分娩的免疫调节

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2019-03-29148

OAAI

Progesterone Modulation of Pregnancy-Related Immune Responses

FRONTIERS IN IMMUNOLOGY

IF5.9

2018-06-2068

OAAI

Changes in T Cell and Dendritic Cell Phenotype from Mid to Late Pregnancy Are Indicative of a Shift from Immune Tolerance to Immune Activation.

FRONTIERS IN IMMUNOLOGY

IF5.9

2017-09-1563

OAAI

Enrichment of HLA Types and Single-Nucleotide Polymorphism Associated With Non-progression in a Strictly Defined Cohort of HIV-1 Controllers

FRONTIERS IN IMMUNOLOGY

IF5.9

2017-06-275

OAAI

Programmed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma: A pilot study

IF6.3

2017-04-0715

OAAI

Myometrial cytokines and their role in the onset of labour

JOURNAL OF ENDOCRINOLOGY

IF3.9

2016-12-0162

OAAI

Multifarious immunotherapeutic approaches to cure HIV-1 infection

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2015-06-055

OAAI

Low-dose growth hormone for 40 weeks induces HIV-1-specific T cell responses in patients on effective combination anti-retroviral therapy

CLINICAL AND EXPERIMENTAL IMMUNOLOGY

IF3.8

2013-08-0617

OAAI

Long-term non-progression and broad HIV-1-specific proliferative T-cell responses

FRONTIERS IN IMMUNOLOGY

IF5.9

2013-01-0120

OAAI

Dysregulated immunophenotypic attributes of plasmacytoid but not myeloid dendritic cells in HIV-1 infected individuals in the absence of highly active anti-retroviral therapy

CLINICAL AND EXPERIMENTAL IMMUNOLOGY

IF3.8

2012-10-0519

OA

CCR5 Antagonism Impacts Vaccination Response and Immune Profile in HIV-1 Infection

MOLECULAR MEDICINE

IF6.4

2012-08-0720

OAAI

Single-Nucleotide Polymorphism-Defined Class I and Class III Major Histocompatibility Complex Genetic Subregions Contribute to Natural Long-term Nonprogression in HIV Infection

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2012-01-1129

PREAI

T-cell signalling in antiretroviral-treated, aviraemic HIV-1-positive individuals is present in a raised state of basal activation that contributes to T-cell hyporesponsiveness

IF3.1

2011-10-234

OAAI